Clinical trials
Recruiting Phase 3 trials in Slovenia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Takeda | 2 |
| University Medical Centre Ljubljana | 2 |
| AB Science | 1 |
| Amgen | 1 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| GRIN Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 1 |
| Antithrombin III Deficiency | 1 |
| Brain Injuries, Traumatic | 1 |
| Breast Neoplasms | 1 |
| COVID-19 | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Community-Acquired Pneumonia | 1 |
| Crohn Disease | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Encephalitis, Tick-Borne | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.